5,10-Dideazatetrahydrofolic acid reduces toxicity and deoxyadenosine triphosphate pool expansion in cultured L1210 cells treated with inhibitors of thymidylate synthase

This publication has 19 references indexed in Scilit:

• Increased expression and characterization of two distinct folate binding proteins in murine erythroleukemia cells
  Biochemical Pharmacology, 1994
• Kinetic characteristics of ICI D1694: a quinazoline antifolate which inhibits thymidylate synthase
  Biochemical Pharmacology, 1992
• DNA fragmentation, dATP pool elevation and potentiation of antifolate cytotoxicity in L1210 cells by hypoxanthine
  British Journal of Cancer, 1992
• Inhibition of 2-desamino-2-methyl-10-propagyl-5,8-dideazafolic acid cytotoxicity by 5,10-dideazatetrahydrofolate in L1210 cells with decrease in DNA fragmentation and deoxyadenosine triphosphate pools
  Biochemical Pharmacology, 1991
• The molecular basis of mutations induced by deoxyribonucleoside triphosphate pool imbalances in mammalian cells
  Experimental Cell Research, 1989
• Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
  Journal of Clinical Investigation, 1986
• The cellular pharmacology of methotrexate
  Pharmacology & Therapeutics, 1985
• Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)methyl)prop-2-ynylamino)benzoyl)-l-glutamic acid (CB3717), on human lymphoblastoid cells
  Biochemical Pharmacology, 1983
• Biochemical factors affecting the tightness of 5-fluorodeoxyuridylate binding to human thymidylate synthetase
  Biochemical Pharmacology, 1981
• A potent antitumour quinazoline inhibitor of thymidylate synthetase: Synthesis, biological properties and therapeutic results in mice
  Published by Elsevier ,1981